IMCOOI
NBIX icon

Investment Management Corp of Ontario (IMCO)’s Neurocrine Biosciences NBIX Stock Holding History

Investment Management Corp of Ontario (IMCO)’s Portfolio NBIX Stock Details NBIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Sell
6,059
-1,100
-15% -$163K 0.01% 558
2026
Q1 		$943K Buy
7,159
+500
+8% +$66.3K 0.01% 572
2025
Q4 		$944K Buy
6,659
+2,014
+43% +$292K 0.01% 571
2025
Q3 		$652K Sell
4,645
-2,886
-38% -$391K 0.01% 559
2025
Q2 		$947K Sell
7,531
-400
-5% -$45.9K 0.01% 426
2025
Q1 		$877K Buy
7,931
+3,341
+73% +$423K 0.02% 429
2024
Q4 		$627K Sell
4,590
-188
-4% -$23.3K 0.02% 271
2024
Q3 		$551K Buy
4,778
+1,200
+34% +$165K 0.01% 520
2024
Q2 		$493K Buy
3,578
+600
+20% +$82.3K 0.01% 451
2024
Q1 		$411K Sell
2,978
-700
-19% -$95.6K 0.01% 447
2023
Q4 		$485K Buy
+3,678
New +$423K 0.01% 471
2023
Q1 		– Sell
-9,361
Closed -$1.12M – 202
2022
Q4 		$1.12M Buy
+9,361
New +$1.1M 0.05% 140

Other funds holding NBIX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Investment Management Corp of Ontario (IMCO)'s NBIX Position: Q2 2026 in Review

Investment Management Corp of Ontario (IMCO) reduced its Neurocrine Biosciences (NBIX) stake by 15% in Q2 2026, selling an estimated $163K and leaving 6,059 shares worth $1.02M. The position accounts for 0.01% of the portfolio, ranked #558.

Investment Management Corp of Ontario (IMCO) first reported a position in NBIX in Q4 2022 and has held it in 12 quarters since. The position peaked at $1.12M in Q4 2022. 775 funds tracked by Wall St. Rank hold NBIX as of Q2 2026.

  • Investment Management Corp of Ontario (IMCO) held 6,059 shares of Neurocrine Biosciences worth $1.02M as of Q2 2026.
  • Investment Management Corp of Ontario (IMCO) sold 1,100 Neurocrine Biosciences shares in Q2 2026, an estimated $163K.
  • Neurocrine Biosciences made up 0.01% of Investment Management Corp of Ontario (IMCO)'s portfolio in Q2 2026, its #558 holding.
  • Investment Management Corp of Ontario (IMCO) first reported a position in Neurocrine Biosciences in Q4 2022 and has held it in 12 quarters since.
  • Investment Management Corp of Ontario (IMCO)'s Neurocrine Biosciences position peaked at $1.12M in Q4 2022.
  • 775 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q2 2026.

Based on Investment Management Corp of Ontario (IMCO)'s 13F filing for Q2 2026, filed 14 Aug 2026.